Global Approved COVID-19 Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Approved COVID-19 Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Approved COVID-19 Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Approved COVID-19 Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Approved COVID-19 Vaccines Segment by Type

2.2.1 Component Viral Vaccines

2.2.2 Whole Virus Vaccines

2.3 Approved COVID-19 Vaccines Sales by Type

2.3.1 Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Approved COVID-19 Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Approved COVID-19 Vaccines Sale Price by Type (2017-2022)

2.4 Approved COVID-19 Vaccines Segment by Application

2.4.1 Adults

2.4.2 Children

2.4.3 Elderly

2.5 Approved COVID-19 Vaccines Sales by Application

2.5.1 Global Approved COVID-19 Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Approved COVID-19 Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Approved COVID-19 Vaccines Sale Price by Application (2017-2022)

3 Global Approved COVID-19 Vaccines by Company

3.1 Global Approved COVID-19 Vaccines Breakdown Data by Company

3.1.1 Global Approved COVID-19 Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Approved COVID-19 Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Approved COVID-19 Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Approved COVID-19 Vaccines Revenue by Company (2020-2022)

3.2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Approved COVID-19 Vaccines Sale Price by Company

3.4 Key Manufacturers Approved COVID-19 Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Approved COVID-19 Vaccines Product Location Distribution

3.4.2 Players Approved COVID-19 Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Approved COVID-19 Vaccines by Geographic Region

4.1 World Historic Approved COVID-19 Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Approved COVID-19 Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Approved COVID-19 Vaccines Annual Revenue by Geographic Region

4.2 World Historic Approved COVID-19 Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Approved COVID-19 Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Approved COVID-19 Vaccines Annual Revenue by Country/Region

4.3 Americas Approved COVID-19 Vaccines Sales Growth

4.4 APAC Approved COVID-19 Vaccines Sales Growth

4.5 Europe Approved COVID-19 Vaccines Sales Growth

4.6 Middle East & Africa Approved COVID-19 Vaccines Sales Growth

5 Americas

5.1 Americas Approved COVID-19 Vaccines Sales by Country

5.1.1 Americas Approved COVID-19 Vaccines Sales by Country (2017-2022)

5.1.2 Americas Approved COVID-19 Vaccines Revenue by Country (2017-2022)

5.2 Americas Approved COVID-19 Vaccines Sales by Type

5.3 Americas Approved COVID-19 Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Approved COVID-19 Vaccines Sales by Region

6.1.1 APAC Approved COVID-19 Vaccines Sales by Region (2017-2022)

6.1.2 APAC Approved COVID-19 Vaccines Revenue by Region (2017-2022)

6.2 APAC Approved COVID-19 Vaccines Sales by Type

6.3 APAC Approved COVID-19 Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Approved COVID-19 Vaccines by Country

7.1.1 Europe Approved COVID-19 Vaccines Sales by Country (2017-2022)

7.1.2 Europe Approved COVID-19 Vaccines Revenue by Country (2017-2022)

7.2 Europe Approved COVID-19 Vaccines Sales by Type

7.3 Europe Approved COVID-19 Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Approved COVID-19 Vaccines by Country

8.1.1 Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Approved COVID-19 Vaccines Sales by Type

8.3 Middle East & Africa Approved COVID-19 Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Approved COVID-19 Vaccines

10.3 Manufacturing Process Analysis of Approved COVID-19 Vaccines

10.4 Industry Chain Structure of Approved COVID-19 Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Approved COVID-19 Vaccines Distributors

11.3 Approved COVID-19 Vaccines Customer

12 World Forecast Review for Approved COVID-19 Vaccines by Geographic Region

12.1 Global Approved COVID-19 Vaccines Market Size Forecast by Region

12.1.1 Global Approved COVID-19 Vaccines Forecast by Region (2023-2028)

12.1.2 Global Approved COVID-19 Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Approved COVID-19 Vaccines Forecast by Type

12.7 Global Approved COVID-19 Vaccines Forecast by Application

13 Key Players Analysis

13.1 Moderna

13.1.1 Moderna Company Information

13.1.2 Moderna Approved COVID-19 Vaccines Product Offered

13.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Moderna Main Business Overview

13.1.5 Moderna Latest Developments

13.2 CanSino Biologicals

13.2.1 CanSino Biologicals Company Information

13.2.2 CanSino Biologicals Approved COVID-19 Vaccines Product Offered

13.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CanSino Biologicals Main Business Overview

13.2.5 CanSino Biologicals Latest Developments

13.3 Inovio Pharmaceuticals

13.3.1 Inovio Pharmaceuticals Company Information

13.3.2 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Offered

13.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Inovio Pharmaceuticals Main Business Overview

13.3.5 Inovio Pharmaceuticals Latest Developments

13.4 Shenzhen Geno-Immune Medical Institute

13.4.1 Shenzhen Geno-Immune Medical Institute Company Information

13.4.2 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Offered

13.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Shenzhen Geno-Immune Medical Institute Main Business Overview

13.4.5 Shenzhen Geno-Immune Medical Institute Latest Developments

13.5 GlaxoSmithKine

13.5.1 GlaxoSmithKine Company Information

13.5.2 GlaxoSmithKine Approved COVID-19 Vaccines Product Offered

13.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKine Main Business Overview

13.5.5 GlaxoSmithKine Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Approved COVID-19 Vaccines Product Offered

13.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Johnson＆Johnson

13.7.1 Johnson＆Johnson Company Information

13.7.2 Johnson＆Johnson Approved COVID-19 Vaccines Product Offered

13.7.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson＆Johnson Main Business Overview

13.7.5 Johnson＆Johnson Latest Developments

13.8 Heat Biologics

13.8.1 Heat Biologics Company Information

13.8.2 Heat Biologics Approved COVID-19 Vaccines Product Offered

13.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Heat Biologics Main Business Overview

13.8.5 Heat Biologics Latest Developments

13.9 Sanofi

13.9.1 Sanofi Company Information

13.9.2 Sanofi Approved COVID-19 Vaccines Product Offered

13.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sanofi Main Business Overview

13.9.5 Sanofi Latest Developments

14 Research Findings and Conclusion

Table 1. Approved COVID-19 Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Approved COVID-19 Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Component Viral Vaccines

Table 4. Major Players of Whole Virus Vaccines

Table 5. Global Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)

Table 6. Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Approved COVID-19 Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Approved COVID-19 Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)

Table 11. Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Approved COVID-19 Vaccines Revenue by Application (2017-2022)

Table 13. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Approved COVID-19 Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Approved COVID-19 Vaccines Sales by Company (2020-2022) & (K Units)

Table 16. Global Approved COVID-19 Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Approved COVID-19 Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Approved COVID-19 Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Approved COVID-19 Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Approved COVID-19 Vaccines Producing Area Distribution and Sales Area

Table 21. Players Approved COVID-19 Vaccines Products Offered

Table 22. Approved COVID-19 Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Approved COVID-19 Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Approved COVID-19 Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Approved COVID-19 Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Approved COVID-19 Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Approved COVID-19 Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Approved COVID-19 Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Approved COVID-19 Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Approved COVID-19 Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)

Table 34. Americas Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Approved COVID-19 Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)

Table 38. Americas Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)

Table 40. Americas Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Approved COVID-19 Vaccines Sales by Region (2017-2022) & (K Units)

Table 42. APAC Approved COVID-19 Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Approved COVID-19 Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Approved COVID-19 Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)

Table 46. APAC Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)

Table 48. APAC Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)

Table 50. Europe Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Approved COVID-19 Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)

Table 54. Europe Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)

Table 56. Europe Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Approved COVID-19 Vaccines

Table 66. Key Market Challenges & Risks of Approved COVID-19 Vaccines

Table 67. Key Industry Trends of Approved COVID-19 Vaccines

Table 68. Approved COVID-19 Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Approved COVID-19 Vaccines Distributors List

Table 71. Approved COVID-19 Vaccines Customer List

Table 72. Global Approved COVID-19 Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Approved COVID-19 Vaccines Sales Market Forecast by Region

Table 74. Global Approved COVID-19 Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Approved COVID-19 Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Approved COVID-19 Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Approved COVID-19 Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Approved COVID-19 Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Approved COVID-19 Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Approved COVID-19 Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Approved COVID-19 Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Approved COVID-19 Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Approved COVID-19 Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Approved COVID-19 Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Approved COVID-19 Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Approved COVID-19 Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Approved COVID-19 Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Approved COVID-19 Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Approved COVID-19 Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Moderna Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Moderna Approved COVID-19 Vaccines Product Offered

Table 94. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Moderna Main Business

Table 96. Moderna Latest Developments

Table 97. CanSino Biologicals Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. CanSino Biologicals Approved COVID-19 Vaccines Product Offered

Table 99. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. CanSino Biologicals Main Business

Table 101. CanSino Biologicals Latest Developments

Table 102. Inovio Pharmaceuticals Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Offered

Table 104. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Inovio Pharmaceuticals Main Business

Table 106. Inovio Pharmaceuticals Latest Developments

Table 107. Shenzhen Geno-Immune Medical Institute Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Offered

Table 109. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Shenzhen Geno-Immune Medical Institute Main Business

Table 111. Shenzhen Geno-Immune Medical Institute Latest Developments

Table 112. GlaxoSmithKine Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. GlaxoSmithKine Approved COVID-19 Vaccines Product Offered

Table 114. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. GlaxoSmithKine Main Business

Table 116. GlaxoSmithKine Latest Developments

Table 117. Pfizer Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Pfizer Approved COVID-19 Vaccines Product Offered

Table 119. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Pfizer Main Business

Table 121. Pfizer Latest Developments

Table 122. Johnson＆Johnson Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Johnson＆Johnson Approved COVID-19 Vaccines Product Offered

Table 124. Johnson＆Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Johnson＆Johnson Main Business

Table 126. Johnson＆Johnson Latest Developments

Table 127. Heat Biologics Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Heat Biologics Approved COVID-19 Vaccines Product Offered

Table 129. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Heat Biologics Main Business

Table 131. Heat Biologics Latest Developments

Table 132. Sanofi Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Sanofi Approved COVID-19 Vaccines Product Offered

Table 134. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Sanofi Main Business

Table 136. Sanofi Latest Developments

List of Figures

Figure 1. Picture of Approved COVID-19 Vaccines

Figure 2. Approved COVID-19 Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Approved COVID-19 Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Approved COVID-19 Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Approved COVID-19 Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Component Viral Vaccines

Figure 10. Product Picture of Whole Virus Vaccines

Figure 11. Global Approved COVID-19 Vaccines Sales Market Share by Type in 2021

Figure 12. Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Approved COVID-19 Vaccines Consumed in Adults

Figure 14. Global Approved COVID-19 Vaccines Market: Adults (2017-2022) & (K Units)

Figure 15. Approved COVID-19 Vaccines Consumed in Children

Figure 16. Global Approved COVID-19 Vaccines Market: Children (2017-2022) & (K Units)

Figure 17. Approved COVID-19 Vaccines Consumed in Elderly

Figure 18. Global Approved COVID-19 Vaccines Market: Elderly (2017-2022) & (K Units)

Figure 19. Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Approved COVID-19 Vaccines Revenue Market Share by Application in 2021

Figure 21. Approved COVID-19 Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Approved COVID-19 Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Approved COVID-19 Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Approved COVID-19 Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Approved COVID-19 Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Approved COVID-19 Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Approved COVID-19 Vaccines Sales 2017-2022 (K Units)

Figure 28. Americas Approved COVID-19 Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Approved COVID-19 Vaccines Sales 2017-2022 (K Units)

Figure 30. APAC Approved COVID-19 Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Approved COVID-19 Vaccines Sales 2017-2022 (K Units)

Figure 32. Europe Approved COVID-19 Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Approved COVID-19 Vaccines Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Approved COVID-19 Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Approved COVID-19 Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Approved COVID-19 Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Approved COVID-19 Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Approved COVID-19 Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Approved COVID-19 Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Approved COVID-19 Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Approved COVID-19 Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Approved COVID-19 Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Approved COVID-19 Vaccines

Figure 65. Industry Chain Structure of Approved COVID-19 Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles